| Q55018593 | A Surgical View of Photodynamic Therapy in Oncology: A Review. |
| Q37190425 | A cell-targeted photodynamic nanomedicine strategy for head and neck cancers |
| Q34621214 | A fiberoptic (photodynamic therapy type) device with a photosensitizer and singlet oxygen delivery probe tip for ovarian cancer cell killing. |
| Q34836855 | Adjuvant intraoperative photodynamic therapy in head and neck cancer |
| Q28468315 | Chemophototherapy: An Emerging Treatment Option for Solid Tumors |
| Q30408510 | Controlled light field concentration through turbid biological membrane for phototherapy. |
| Q50231424 | Detection of metastatic lymph nodes using 5-aminolevulinic acid in patients with gastric cancer |
| Q91761666 | Effective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition |
| Q57696765 | Fast uptake, water-soluble, mitochondria-specific erbium complex for a dual function molecular probe – imaging and photodynamic therapy |
| Q37763099 | Future of oncologic photodynamic therapy |
| Q33849055 | In vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancer |
| Q37307865 | Lipid nanoemulsions and liposomes improve photodynamic treatment efficacy and tolerance in CAL-33 tumor bearing nude mice |
| Q37354626 | Monitoring photodynamic therapy of head and neck malignancies with optical spectroscopies |
| Q39437627 | Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles |
| Q35173108 | Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy. |
| Q27348681 | PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro |
| Q51149440 | Photodynamic therapy and diagnosis: Principles and comparative aspects. |
| Q35623101 | Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice |
| Q36995497 | Photodynamic therapy for treatment of solid tumors--potential and technical challenges |
| Q35532394 | Photodynamic therapy of cancer: an update |
| Q37302913 | Photodynamic therapy of tumors with pyropheophorbide-a-loaded polyethylene glycol-poly(lactic-co-glycolic acid) nanoparticles |
| Q36945981 | Photodynamic therapy treatment of early oral and laryngeal cancers |
| Q37547850 | Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity |
| Q35842215 | Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib study |
| Q35766780 | Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response |
| Q36986117 | Photodynamic therapy: basic principles and potential uses for the veterinary ophthalmologist |
| Q38170385 | Photodynamic therapy: oncologic horizons |
| Q36365477 | Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review |
| Q38710646 | Photosensitizers binding to nucleic acids as anticancer agents |
| Q38727026 | Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro |
| Q36156129 | Safety evaluation of repeated intravenous infusion of sinoporphyrin with and without PDT in rats |
| Q34404413 | Shining light on nanotechnology to help repair and regeneration |
| Q90749174 | Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening |
| Q39675468 | TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy. |
| Q37919156 | Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer. |
| Q41963527 | The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model |
| Q35183647 | The effect of photodynamic therapy on cisterna chyli patency in rats |
| Q37170164 | The role of photodynamic therapy (PDT) physics. |
| Q37090135 | Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors |
| Q43170864 | Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate |
| Q82116949 | [Poorly differentiated neuroendocrine carcinoma of the larynx. Diagnostic features, treatment strategy, and prognosis] |